
Keywords: گابا; AAL; automated anatomical labeling; CNS; central nervous system; FDG; F-18-fluorodeoxyglucose; GABA; gamma-butyric acid; NF1; neurofibromatosis type 1; NPT; neuropsychological testing; PET; positron emission tomography; PNST; peripheral nerve sheet tumors